-
Track & Monitor
Partnerships, Licensing, Investments and M&A Deals and Trends for May 2017 in Pharmaceuticals
The pharmaceutical and healthcare industry reported an increase in the number of deals and deal values in May 2017. The industry reported 373 deals worth USD37.8 billion in May 2017, compared to 307 deals worth USD21.5 billion in April 2017. The oncology therapeutics market remained at the top in deal activity in May 2017 with 126 deals. In second place, central nervous system therapeutics market reported 84 deals. Licensing agreements in pharmaceutical and healthcare industry registered a decrease in upfront...
-
Product Insights
Hyperprolactinaemia Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Hyperprolactinaemia Global Clinical Trials Review, H2, 2017" provides an overview of Hyperprolactinaemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperprolactinaemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Sector Analysis
PharmaPoint: Epilepsy – Global Drug Forecast and Market Analysis to 2026
Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. Seizures result from abnormal electrical discharges in the brain and vary in their manifestations, from the brief staring spells that are characteristic of absence seizures, to full-body convulsions known as tonic-clonic seizure. Epilepsy can be considered a spectrum disorder due to its different causes, different seizure types, and different disease severities. There are several anti-epileptic drugs (AEDs) on the market, with an older generation fully genericized across the...
-
Track & Monitor
PharmSource – M&A in the Contract Manufacturing Industry: Implications and Outlook – 2018 Edition
This report is the 2nd edition of our analysis of Mergers and Acquisitions in the contract manufacturing industry. PharmSource is the most definitive, trustworthy source of strategic insight on this topic in the bio/pharmaceutical realm.
-
Product Insights
Syphilis Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Syphilis Global Clinical Trials Review, H2, 2016" provides an overview of Syphilis clinical trials scenario. This report provides top line data relating to the clinical trials on Syphilis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Agoraphobia Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Agoraphobia Global Clinical Trials Review, H1, 2017" provides an overview of Agoraphobia clinical trials scenario. This report provides top line data relating to the clinical trials on Agoraphobia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Shigella Infections (Shigellosis) Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Shigella Infections (Shigellosis) Global Clinical Trials Review, H1, 2016" provides an overview of Shigella Infections (Shigellosis) clinical trials scenario. This report provides top line data relating to the clinical trials on Shigella Infections (Shigellosis). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Pneumococcal Meningitis Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Pneumococcal Meningitis Global Clinical Trials Review, H2, 2016" provides an overview of Pneumococcal Meningitis clinical trials scenario. This report provides top line data relating to the clinical trials on Pneumococcal Meningitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Agoraphobia Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Agoraphobia Global Clinical Trials Review, H2, 2016" provides an overview of Agoraphobia clinical trials scenario. This report provides top line data relating to the clinical trials on Agoraphobia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...